IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B
705.47
USD
6.86
(0.98%)
Market Open
Last updated: · Delayed 15 min
Fair value719.99Plus-2%498Price 705.471,107
Q4 FY2026 · Earnings report
EPS estimate 3.30Revenue estimate 1.18B
OverviewFinancialsForecastEarningsCompany

IDEXX Laboratories revenue 1991–2026

IDEXX Laboratories's revenue in Q3 FY2026, the three months to 30 September 2026, was 1.21B USD, up 9.9% on the same quarter a year before. IDEXX Laboratories's revenue over the last twelve months was 4.66B USD, up 11.9% on the twelve months before. In fiscal year 2025 it was 4.30B USD, up 10.4% on the year before.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 20264.66B+11.87%2.92B1.18B
FY202531 Dec 20254.30B+10.42%2.66B1.06B
FY202431 Dec 20243.90B+6.46%2.38B887.87M
FY202331 Dec 20233.66B+8.72%2.19B845.04M
FY202231 Dec 20223.37B+4.73%2.00B679.09M
FY202131 Dec 20213.22B+18.79%1.89B744.85M
FY202031 Dec 20202.71B+12.45%1.57B581.78M
FY201931 Dec 20192.41B+8.75%1.37B427.72M
FY201831 Dec 20182.21B+12.40%1.24B377.03M
FY201731 Dec 20171.97B+10.91%1.10B263.14M
FY201631 Dec 20161.78B+10.83%975.44M222.05M
FY201531 Dec 20151.60B+7.81%890.27M192.08M
FY201431 Dec 20141.49B+7.90%816.12M181.91M
FY201331 Dec 20131.38B+6.47%756.12M187.80M
FY201231 Dec 20121.29B+6.13%699.15M178.27M
FY201131 Dec 20111.22B+10.45%646.51M161.79M
FY201031 Dec 20101.10B+6.96%578.62M141.28M
FY200931 Dec 20091.03B+0.74%526.28M122.23M
FY200831 Dec 20081.02B+11.00%529.77M116.17M
FY200731 Dec 2007922.56M+24.82%463.52M94.01M
FY200631 Dec 2006739.12M+15.83%379.53M93.68M
FY200531 Dec 2005638.10M+16.19%322.90M78.25M
FY200431 Dec 2004549.18M+15.38%279.02M78.33M
FY200331 Dec 2003475.99M+15.34%230.30M57.09M
FY200231 Dec 2002412.67M+6.89%192.73M45.39M
FY200131 Dec 2001386.08M+5.08%183.33M37.62M
FY200031 Dec 2000367.43M+3.15%196.66M36.63M
FY199931 Dec 1999356.20M+11.35%191.30M32.60M
FY199831 Dec 1998319.90M+21.63%177.70M-15.20M
FY199731 Dec 1997263.00M-1.76%143.20M-21.10M
FY199631 Dec 1996267.70M+41.94%164.80M32.60M
FY199531 Dec 1995188.60M+49.21%113.40M21.50M
FY199431 Dec 1994126.40M+35.77%77.70M13.30M
FY199331 Dec 199393.10M+61.35%58.90M9.70M
FY199231 Dec 199257.70M+89.18%36.00M4.90M
FY199131 Dec 199130.50M—18.70M3.20M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

IDEXX Laboratories revenue growth by segment

Q3 FY2026 against Q3 FY2025

Product722.86M
+10.2%
Service491.38M
+9.4%

IDEXX Laboratories revenue by segment over time

Product Service Cag Rapid Assay Products Reagent Rental Programs Instrument Rebate Programs Extended Warranties And Post Contract Support Up Front Customer Loyalty Programs And Volume Commitment Programs
Fiscal yearProductServiceCagRapid Assay ProductsReagent Rental ProgramsInstrument Rebate ProgramsExtended Warranties And Post Contract SupportUp Front Customer Loyalty Programs And Volume Commitment Programs
FY20252.54B +12.9%1.76B +7.0%— — — — — —
FY20242.25B +7.6%1.65B +5.0%— — — — — —
FY20232.09B 1.57B — — — — — —
FY2022— — — — 42.80M +11.7%12.00M -16.1%21.30M -7.8%3.20B +10.3%
FY2021— — — — 38.30M +54.4%14.30M -12.3%23.10M +5.0%2.90B +31.8%
FY2020— — — — 24.80M -21.5%16.30M -9.9%22.00M -9.8%2.20B +15.8%
FY2019— — — — 31.60M -36.3%18.10M -0.5%24.40M -11.9%1.90B +46.2%
FY2018— — — — 49.60M 18.20M 27.70M 1.30B
FY2017— — — 205.31M — — — —
FY2016— — 1.28B +11.8%— — — — —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about IDEXX Laboratories's revenue

Source: Financial Modeling Prep